Home » Bureaus/Offices Reporting Directly to the Secretary » Office of the Legal Adviser » International Claims and Investment Disputes (L/CID) » NAFTA Investor-State Arbitrations » Cases Filed Against the Government of Canada » Eli Lilly and Co. v. Government of Canada
Eli Lilly and Co., incorporated in Indiana, filed a claim against the Government of Canada relating to the Canadian courts’ invalidation of patents for two pharmaceutical products, Strattera and Zyprexa. Claimant alleges that Canada has violated NAFTA Articles 1110 (“Expropriation and Compensation”) and 1105 (“Minimum Standard of Treatment”).
For further information and documents concerning this claim, click here.
The Office of Website Management, Bureau of Public Affairs, manages this site as a portal for information from the U.S. State Department.
External links to other Internet sites should not be construed as an endorsement of the views or privacy policies contained therein.